Erimos Pharmaceuticals: Clinical Trials

6 trials sponsored by Erimos Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Terminated 2
Phase 21Completed 1

Follow Erimos Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Terameprocol in Treating Patients With Recurrent High Grade Glioma
Terameprocol, Pharmacological Study - High Grade Glioma (III or IV)
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins202018-05-032023-10-06
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia
Terameprocol (EM-1421) - Leukemias, Acute Myeloid Leukemia (AML)
Phase 1TerminatedErimos Pharmaceuticals162007-08-012016-02-23
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
Terameprocol (EM-1421) - Refractory Solid Tumors, Lymphoma
Phase 1TerminatedErimos Pharmaceuticals212007-05-012016-02-23
Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors
EM-1421 - Cancer
Phase 1CompletedErimos Pharmaceuticals302005-12-012008-01-24
A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
EM-1421 - Cervical Intraepithelial Neoplasia
Phase 1 / Phase 2CompletedErimos Pharmaceuticals82004-11-012016-02-23
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
M4N - Head and Neck Neoplasms
Phase 1CompletedErimos Pharmaceuticals92003-01-012016-02-23

Conditions studied

Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Uterine Cervical Dysplasia (1)

Interventions

terameprocol (6)

Countries

United States (6)

Top investigators

Neil Frazer, MB, ChB (2)  ·  Manmeet Ahluwalia, MD (1)  ·  Neil Frazer, MB (1)

Results publications

PMID 38955178

NIH funding

UM1CA137443 (1)